Junko Kajikuri Selected Research

Junko Kajikuri Research Topics

Disease

4	Neoplasms (Cancer) 10/2023 - 01/2019
4	Hyperplasia 07/2017 - 07/2007
3	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 01/2019
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 09/2018
3	Breast Neoplasms (Breast Cancer) 09/2021 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 11/2017 - 01/2014
2	Chondrosarcoma 10/2023 - 09/2021
2	Triple Negative Breast Neoplasms 01/2019 - 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 10/2023
1	Inflammation (Inflammations) 01/2021
1	Diarrhea 01/2021
1	Hypoxia (Hypoxemia) 12/2019
1	Carcinogenesis 01/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Peripheral Arterial Disease 11/2017
1	Arteriosclerosis 11/2017
1	Hyperglycemia 11/2017
1	Diabetes Mellitus 11/2017
1	Hyperhomocysteinemia 06/2010
1	Spasm (Spasms) 09/2009
1	Neointima 07/2007
1	Pre-Eclampsia (Preeclampsia) 11/2002

Drug/Important Bio-Agent (IBA)

4	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 09/2021
3	Superoxides (Superoxide)IBA 11/2017 - 07/2007
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2017 - 07/2007
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2021 - 09/2021
2	Androgen Antagonists (Antiandrogens)IBA 12/2021 - 01/2018
2	CytokinesIBA 01/2019 - 09/2018
1	Cytochrome P-450 CYP3A InhibitorsIBA 10/2023
1	Ketoconazole (Nizoral)FDA LinkGeneric 10/2023
1	Multidrug Resistance-Associated ProteinsIBA 10/2023
1	Small Interfering RNA (siRNA)IBA 10/2023
1	Cytochrome P-450 CYP3AIBA 10/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2021
1	Cisplatin (Platino)FDA LinkGeneric 09/2021
1	UbiquitinIBA 09/2021
1	Positive Regulatory Domain I-Binding Factor 1IBA 01/2021
1	TRAM 34IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 12/2019
1	FM19G11IBA 12/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	ChloridesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	PotassiumIBA 01/2019
1	CalciumIBA 01/2019
1	Androgen Receptor AntagonistsIBA 01/2019
1	InterferonsIBA 09/2018
1	human ERBB2 proteinIBA 09/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	AndrogensIBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	Advanced Glycation End ProductsIBA 11/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2016
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2016
1	VildagliptinIBA 01/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2014
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2014
1	Protein Kinase CIBA 01/2014
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 06/2010
1	mecobalamin (methylcobalamin)IBA 06/2010
1	Serotonin (5 Hydroxytryptamine)IBA 09/2009
1	sarpogrelateIBA 05/2009
1	Celiprolol (ST1396)IBA 07/2007
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 07/2007
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 11/2002
1	BradykininIBA 11/2002
1	ProstaglandinsIBA 11/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2021
1	Therapeutics 09/2018
1	Glycemic Control 01/2016
1	Renal Dialysis (Hemodialysis) 06/2010